Atlas Trials

Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer

Clinical trial NCT00445523 · COMPLETED

Trial details

NCT number
NCT00445523
Sponsor
The Methodist Hospital Research Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal Cell
Start date
2006-05-01
Primary completion
2008-01-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.